IntegraGen S.A.
ALINT.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €4 | €6 | €8 | €7 |
| - Cash | €2 | €2 | €2 | €3 |
| + Debt | €1 | €1 | €2 | €2 |
| Enterprise Value | €3 | €5 | €7 | €6 |
| Revenue | €9 | €13 | €13 | €11 |
| % Growth | -30.6% | -4.8% | 16.3% | – |
| Gross Profit | €2 | -€0 | -€0 | €0 |
| % Margin | 20.5% | -0.1% | -0% | 0.4% |
| EBITDA | -€0 | -€0 | €0 | €0 |
| % Margin | -3.4% | -0.4% | 0.5% | 0.9% |
| Net Income | -€0 | -€0 | -€0 | €0 |
| % Margin | -2.9% | -1.4% | -0% | 0.1% |
| EPS Diluted | -0.038 | -0.026 | -0.001 | 0.002 |
| % Growth | -46.7% | -5,080% | -121.7% | – |
| Operating Cash Flow | €0 | €0 | €0 | €0 |
| Capital Expenditures | €0 | €0 | €0 | €0 |
| Free Cash Flow | €0 | €0 | €0 | €0 |